Does TACROLIMUS Cause Product use issue? 971 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 971 reports of Product use issue have been filed in association with TACROLIMUS (Tacrolimus). This represents 1.1% of all adverse event reports for TACROLIMUS.
971
Reports of Product use issue with TACROLIMUS
1.1%
of all TACROLIMUS reports
148
Deaths
289
Hospitalizations
How Dangerous Is Product use issue From TACROLIMUS?
Of the 971 reports, 148 (15.2%) resulted in death, 289 (29.8%) required hospitalization, and 110 (11.3%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 971 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which TACROLIMUS Alternatives Have Lower Product use issue Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB